Elizabeth Bullitt - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Elizabeth Bullitt

Showing results (31-40 of 33) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 33 results.

Clinical Breast Cancer|June 24, 2011

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastasesRachel A Freedman, Elizabeth Bullitt, Lixian Sun, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 12, 2013

Evolutionary etiology of high-grade astrocytomasYurong Song, Qian Zhang, Burak Kutlu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancerNancy U Lin, Lisa A Carey, Minetta C Liu, et al.

Pageof 4

Search research articles

Showing results (31-40 of 33) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 33 results.

Clinical Breast Cancer|June 24, 2011

A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastasesRachel A Freedman, Elizabeth Bullitt, Lixian Sun, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 12, 2013

Evolutionary etiology of high-grade astrocytomasYurong Song, Qian Zhang, Burak Kutlu, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008

Phase II trial of lapatinib for brain metastases in patients with human epidermal growth factor receptor 2-positive breast cancerNancy U Lin, Lisa A Carey, Minetta C Liu, et al.

Pageof 4